Related Experiment Video
Updated: Dec 6, 2025

Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys
Published on: August 12, 2021
An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD.
Jonathan Taylor1, Richard Thomas1, Peter Metherall1
13DLab, Medical Imaging Medical Physics, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
An artificial intelligence (AI) tool accurately measures total kidney volume (TKV) in autosomal dominant polycystic kidney disease (ADPKD) patients. This AI method is faster and precise for clinical use, aiding in prognosis.
Area of Science:
- Nephrology
- Medical Imaging
- Artificial Intelligence
Background:
- Accurate prognosis tools for autosomal dominant polycystic kidney disease (ADPKD) are currently limited.
- Total kidney volume (TKV) is a key indicator for ADPKD progression and prognosis.
- Manual segmentation of kidney volume from MRI scans is time-consuming and subject to inter-observer variability.
Purpose of the Study:
- To develop and validate an artificial intelligence (AI)-based method for automated and routine measurement of TKV in ADPKD patients.
- To assess the performance of the AI tool compared to manual segmentation by human experts.
Main Methods:
- An ensemble U-net algorithm was developed using the nnUNet framework.
- The AI model was trained and internally validated on 1.5T MRI data from the CYSTic consortium (454 kidneys, 227 scans), with manual segmentation by a single operator.
- Independent validation was performed on 48 clinical MRI scans segmented by 6 different analysts.
Main Results:
- The AI algorithm achieved a median DICE score of 0.96 for both left and right kidneys, with a median TKV error of -1.8% on clinical validation data.
- Automated segmentation significantly reduced processing time, from 56 (±28) minutes for manual segmentation to 8.5 (±9.2) minutes for AI-assisted correction.
- The AI tool demonstrated high precision and accuracy comparable to manual segmentation.
Conclusions:
- The developed AI-based algorithm provides accurate and efficient TKV measurements in ADPKD patients.
- The tool's performance in real-world clinical settings indicates its suitability for routine application.
- This AI method has the potential to improve individual prognosis assessment in ADPKD.
More Related Videos
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies I: Kidney, Ureter, and Bladder Studies

